Third Rock tops STAT’s VC rankings, boosted by early biotech investments
Third Rock Ventures delivered the best returns among 22 prominent biotech venture capital firms analyzed by STAT.
Previous Post
Imperial trials at-home monitoring service for dementia patients
Next Post
STAT+: The most burdensome diseases globally are the least studied, but the gap is narrowing
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago